Picture of Amneal Pharmaceuticals logo

AMRX Amneal Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Brief: Amneal Says Raising 2024 Full Year Guidance

Aug 9 (Reuters) - Amneal Pharmaceuticals Inc  AMRX.N :
    * AMNEAL REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
    * SAYS RAISING 2024 FULL YEAR GUIDANCE
    * QTRLY EARNINGS PER SHARE $0.02
    * QTRLY ADJUSTED EARNINGS PER SHARE $0.16
    * NOW  SEES FY 2024 NET REVENUE$2.70 BILLION - $2.80 BILLION
    * NOW SEES FY 2024 ADJUSTED EARNINGS PER SHARE $0.57 - $0.63
    * QTRLY REVENUES $701.8 MILLION
    * Q2 EARNINGS PER SHARE VIEW $0.14, REVENUE VIEW $658.1
MILLION --
LSEG IBES DATA
    * FY2024 EARNINGS PER SHARE VIEW $0.61, REVENUE VIEW $2.65
BILLION
-- LSEG IBES DATA

Source text for Eikon:  ID:nBw5MyxTna 
Further company coverage:  AMRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amneal Pharmaceuticals

See all news